drugset / Trial / NCT07333183
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a Phase 2, open-label, multi-center clinical study to evaluate the safety and tolerability of inhaled mosliciguat in participants with pulmonary hypertension associated with interstitial lung disease (PH-ILD) on a background inhaled treprostinil.
Timeline
- Start
- 2025-12-23
- Primary completion
- 2026-12
- Completion
- 2028-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mosliciguat | Unknown | — | Inhaled |